PROCEDES DE TRAITEMENT DE CANCERS AU MOYEN D'ANTAGONISTES SE LIANT A L'AXE PD-1 ET D'ANTICORPS ANTI-GPC3

• 收藏
• 分享

专利权人:

GENENTECH, INC.;CHUGAI SEIYAKU KABUSHIKI KAISHA; INC.;GENENTECH

发明人:

ENDO, MIKA,KATO, ATSUHIKO,OHTOMO, TOSHIHIKO,ADACHI, KENJI,KINOSHITA, YASUKO,NARITA, YOSHINORI

申请号：

CA3016552

公开号：

CA3016552A1

申请日:

2017.03.14

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The disclosure provides compositions and methods for treating cancers. The methods comprising administering a PD-1 axis binding antagonist and an anti-GPC3 antibody. The compositions comprising a pharmaceutical composition for treating cancer which comprises a PD-1 axis binding antagonist and an anti-GPC3 antibody. Also disclosed are a pharmaceutical composition to be used in combination with a PD-1 axis binding antagonist for treating cancer which comprises an anti-GPC3 antibody as the active ingredient； and a pharmaceutical composition to be used in combination with an anti-GPC3 antibody for treating cancer which comprises as the active ingredient a PD-1 axis binding antagonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/